Header Car Icon

get free! shipping on orders over $100

Myopia Control

Default Promotional Image

22

April 2020

Myopia Control

Myopia Control

If there is a family history of myopia and myopia is increasing year on year then there is now proven options to slow the rate of progression. Myopia small or large is not desirable and carries with it an increased risk of a retinal detachment or glaucoma later in life. Even -1.00D doubles the risk of an event causing permanent loss is vision in their lifetime compared to a person who is not shortsighted. -5.00 patients have a 32 times risk compared to a person who is not shortsighted. So controlling the myopia progression in those early vital years to lower the eventual amount of myopia is important.

MiyoSmart

MiyoSmart is an innovative spectacle lens for myopia control developed by Hoya together with its research collaborator. Based on a two-year clinical trial results, MiyoSmart is proven to curb myopia progression in children in average by 60% with its award-winning D.I.M.S. (Defocus Incorporated Multiple Segments) technology.

Find out more on how you can address concerns on myopia progression with MiyoSmart

More info

MiSight™

Mi-Sight daily disposable contact lenses are designed specifically for myopia control and released in 2019 with scientific data that proves they work. They are designed to be worn 12 hours 6 days a week from as young as eight when myopia can start until late teens when the myopia has usually flattened off. They have been proven to produce a 59% drop in the rate of myopia progression after three years compared to children wearing standard soft dailies (CooperVision Research)

The contact lenses are designed with ActivControl™ Technology to create separate zones within the contact lenses. The zones target individual aspects of the eye, specific zones correct and clear your vision and other zones optically treat and help to slow myopic eye growth.

 

Please click here to print off our informative handout

https://coopervision.com.my/contact-lenses/misight

Low Dose 0.01% Atropine drops as an alternative to control myopia